Tirzepatide, hair loss, and TRT: separating real side effects from TikTok fear

What's this video probably claiming?

Based on the caption and hashtags, @danibroach21 appears to be sharing a personal experience involving hair loss connected to either tirzepatide use, TRT, or both simultaneously. The #justbeinghonest and #transparency framing suggests this is a first-person account, likely describing unexpected shedding after starting one or both treatments. The SAHM (stay-at-home mom) context adds a layer: this is probably a woman sharing a real and distressing cosmetic side effect, possibly framing it as something her provider didn't warn her about. The tirzepatide hashtag is misspelled (#trizepatide), which is common in organic creator posts and suggests this isn't sponsored content. The core implicit claim is likely something like: tirzepatide (and/or hormones) caused my hair to fall out, and nobody told me this would happen.

What does the science actually show?

Hair loss after rapid weight loss is a well-documented phenomenon called telogen effluvium. It has nothing to do with tirzepatide specifically and everything to do with caloric restriction and physiological stress. A 2022 review in Dermatology and Therapy (Asghar et al.) confirmed that any significant caloric deficit triggering more than 1-2 lbs per week of loss can push hair follicles prematurely into the telogen (shedding) phase. In the SURMOUNT-1 trial published in NEJM (Jastreboff et al., 2022), tirzepatide at 15mg produced roughly 20-22% body weight loss over 72 weeks. That magnitude of weight loss virtually guarantees some degree of telogen effluvium in a subset of patients. On the TRT side, testosterone can elevate DHT, which does accelerate androgenetic alopecia in genetically susceptible individuals. But acute shedding within weeks of starting TRT is almost always telogen effluvium, not androgen-driven loss.

Where does the social media noise diverge from clinical reality?

The TikTok conversation around GLP-1 and hair loss has a consistency problem. Creators conflate three distinct mechanisms, and their audiences have no reason to separate them. First: telogen effluvium from weight loss (temporary, resolves in 3-6 months after stabilization). Second: androgenetic alopecia from elevated DHT on TRT (chronic, progressive without intervention). Third: nutritional deficiency, particularly protein and iron, which is extremely common in patients losing weight rapidly on GLP-1 agonists due to appetite suppression. A 2021 study in Obesity Reviews (Pucci and Finer) noted that protein intake frequently drops below 60g per day in aggressive GLP-1 responders, which independently causes shedding. Most TikTok creators, including likely this one, present all three as a single problem with a single cause. That's not accurate and it leads patients to either panic unnecessarily or attribute the wrong cause, which delays the right fix.

What should you actually know?

If you're losing hair on tirzepatide, TRT, or both, the single most important thing to do before drawing conclusions is get bloodwork. Ferritin below 30 ng/mL is a common and correctable driver of shedding that gets missed constantly. Protein intake below 1g per kg of body weight in a caloric deficit compounds the problem significantly. Telogen effluvium is self-limiting in most cases: shedding typically peaks around month 3-4 and resolves by month 6-9 after weight stabilizes. Androgenetic alopecia from elevated DHT is a separate condition that requires different management, including potential use of finasteride or topical minoxidil, and that decision belongs with a licensed provider. This video, however relatable and well-intentioned, likely does not distinguish between these pathways. Patients who make treatment decisions based on TikTok testimonials about hair loss risk either abandoning an effective weight loss treatment prematurely or ignoring a fixable nutritional gap.